Biofrontera AG (B8FGn)

1.600
-0.100(-5.88%)
  • Volume:
    1,710
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    1.560 - 1.660
  • Type:Equity
  • Market:Germany
  • ISIN:DE0006046113
  • WKN:604611

B8FGn Overview

Prev. Close
1.7
Day's Range
1.56-1.66
Revenue
28M
Open
1.56
52 wk Range
1.56-3.64
EPS
-0.28
Volume
1,710
Market Cap
95.29M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,341
P/E Ratio
-
Beta
1.2
1-Year Change
-47.54%
Shares Outstanding
56,717,385
Next Earnings Date
Apr 13, 2022
What is your sentiment on Biofrontera AG?
or
Market is currently closed. Voting is open during market hours.

Biofrontera AG Company Profile

Employees
159
Market
Germany

Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma. Further, the company’s product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.